BioWorld6 小时
Med-tech gainers and losers for Jan. 3-10, 2025
Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...
BioWorld7 小时
Biggest gainers and losers for Jan. 6-10, 2025
Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...
BioWorld21 小时
Caplyta to J&J with $14.6B buyout of Intra-Cellular
Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...